...
首页> 外文期刊>Cardiology in review >Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options
【24h】

Peripartum Cardiomyopathy Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology, and Treatment Options

机译:Peripartum心肌病发生率,危险因素,诊断标准,病理生理学和治疗方案

获取原文
获取原文并翻译 | 示例
           

摘要

Peripartum cardiomyopathy is a rare and a severe form of heart failure that affects women during pregnancy or shortly after delivery. Risk factors include advanced age, race, multiparity, multifetal pregnancy, socioeconomic disparity, and medical comorbidities including systemic hypertension, diabetes, asthma, and anemia. Peripartum cardiomyopathy is associated with increased morbidity and mortality, as well as a detrimental long-term impact on quality of life. Its etiology is not clear, although it is thought to be a combined effect of a hyperdynamic fluid state associated with pregnancy, hormonal changes unique to gestation, and a genetic predisposition. There is no current expert consensus on an optimal treatment regimen. This article will provide a comprehensive review and update on this important disease state.
机译:Peripartum心肌病是一种罕见和严重的心力衰竭,影响孕妇在妊娠期间或交付后不久。 危险因素包括晚期,种族,多平度,多重妊娠,社会经济差异和医疗合并症,包括全身性高血压,糖尿病,哮喘和贫血。 Peripartum心肌病与发病率和死亡率增加有关,以及对生活质量的不利影响。 其病因尚不清楚,虽然被认为是与妊娠相关的超动态流体状态的综合作用,妊娠的荷尔蒙变化以及遗传易感性。 没有关于最佳治疗方案的专家共识。 本文将对这一重要疾病状态提供全面的审查和更新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号